Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism DR5 inhibitors(Tumor necrosis factor receptor superfamily member 10B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal Carcinoma | Phase 2 | China | 01 Sep 2019 | |
Glioma | Phase 2 | China | 01 Sep 2019 | |
Hepatocellular Carcinoma | Phase 2 | China | 01 Sep 2019 | |
Stomach Cancer | Phase 2 | China | 01 Sep 2019 |